Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers

Cytokine. 2023 Sep:169:156280. doi: 10.1016/j.cyto.2023.156280. Epub 2023 Jun 23.

Abstract

Objectives: To investigate the clinical significance of serum cytokine profiles for differentiating between Kawasaki disease (KD) and its mimickers.

Methods: Patients with KD, including complete KD, KD shock syndrome (KDSS), and KD with macrophage activation syndrome (KD-MAS), and its mimickers, including multisystem inflammatory syndrome in children, toxic shock syndrome, and Yersinia pseudotuberculosis infection, were enrolled. Serum levels of interleukin (IL)-6, soluble tumor necrosis factor receptor type II (sTNF-RII), IL-10, IL-18, and chemokine (C-X-C motif) ligand 9 (CXCL9) were measured using enzyme-linked immunosorbent assay and compared them with clinical manifestations.

Results: Serum IL-6, sTNF-RII, and IL-10 levels were significantly elevated in patients with KDSS. Serum IL-18 levels were substantially elevated in patients with KD-MAS. Patients with KD-MAS and KD mimickers had significantly elevated serum CXCL9 levels compared with those with complete KD. Area under the receiver operating characteristic curve analysis showed that serum IL-6 was the most useful for differentiating KDSS from the others, IL-18 and CXCL9 for KD-MAS from complete KD, and CXCL9 for KD mimickers from complete KD and KD-MAS.

Conclusion: Serum cytokine profiles may be useful for differentiating between KD and its mimickers.

Keywords: Cytokine; Kawasaki disease; Macrophage activation syndrome; Multisystem inflammatory syndrome in children; Toxic shock syndrome; Yersinia pseudotuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Chemokine CXCL9 / blood
  • Child
  • Cytokines* / blood
  • Diagnosis, Differential
  • Female
  • Humans
  • Interleukin-6 / blood
  • Macrophage Activation Syndrome / blood
  • Macrophage Activation Syndrome / diagnosis
  • Male
  • Middle Aged
  • Mucocutaneous Lymph Node Syndrome* / blood
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • Shock, Septic* / blood
  • Shock, Septic* / diagnosis
  • Systemic Inflammatory Response Syndrome* / blood
  • Systemic Inflammatory Response Syndrome* / diagnosis
  • Yersinia pseudotuberculosis Infections* / blood
  • Yersinia pseudotuberculosis Infections* / diagnosis
  • Young Adult

Substances

  • Cytokines
  • Interleukin-6
  • Chemokine CXCL9

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related